2015
DOI: 10.1097/prs.0000000000001284
|View full text |Cite
|
Sign up to set email alerts
|

Osteoprotegerin Deficiency Results in Disruption of Posterofrontal Suture Closure in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“… 12 In mice, the posterior frontal suture typically fuses around three weeks after birth, but it exhibits persistent patency in mice lacking osteoprotegerin (OPG), which inhibits osteoclastogenesis by antagonising receptor activator of nuclear factor kappa-B ligand (RANKL). 13 Moreover, downregulation of another osteoclast regulator, receptor activator of nuclear factor kappa-B (RANK), also results in increased bone formation at the suture. 14 …”
Section: Introductionmentioning
confidence: 99%
“… 12 In mice, the posterior frontal suture typically fuses around three weeks after birth, but it exhibits persistent patency in mice lacking osteoprotegerin (OPG), which inhibits osteoclastogenesis by antagonising receptor activator of nuclear factor kappa-B ligand (RANKL). 13 Moreover, downregulation of another osteoclast regulator, receptor activator of nuclear factor kappa-B (RANK), also results in increased bone formation at the suture. 14 …”
Section: Introductionmentioning
confidence: 99%
“…However, a reduction or to delay in the suture fusion also plays a key role in shaping the skull. In the case of the OPG KO mouse model, an OPG deficiency created a reduced fusion of the interfrontal suture which was coupled with a shortened skull morphology in the anterior-posterior direction (brachycephaly) ( Beederman et al, 2015 ). Evidence from mouse models suggests that sutures, irrespective of the closure status, can serve as targets for developmental changes that affect the overall cranial morphology.…”
Section: Sutures As Targets For Evolutionary Change In Skull Morphologymentioning
confidence: 99%
“…The patency and osseous obliteration of a suture is largely controlled by the bone remodelling activity of osteoclasts and osteoblasts. A balance between these bone remodelling cells (osteoclasts and osteoblasts) is required for suture homeostasis and the maintenance of a patent suture ( Beederman et al, 2015 ). Given the role of osteoclasts and osteoblasts in determining suture fusion status in mammals, they have a crucial role in regulating the cranial bone growth capacity at the suture.…”
Section: Possible Mechanisms For Evolutionary Changementioning
confidence: 99%
See 2 more Smart Citations